Skip navigation

Proactive Strategies for Managing Risk in Patient Support Services, Specialty Pharmacy Contracting and Non-Promotional Activities

September 13-14, 2018
  • Boston, MA

CBI’s Compliance Congress for Specialty Products serves as the life sciences industry’s only conference catered to the unique compliance challenges for specialty bio/pharmaceutical companies, pre- and post-commercialization.

While specialty products are immensely valuable to patients, they also bring unprecedented risks for manufacturers. A comprehensive compliance program is essential to correctly assessing risks, including patient assistance programs, non-commercial activities, third-party relationships and pharmacy contracting. At this fourth annual meeting, take the opportunity to identify and address the top risk areas for specialty product manufacturers and compare strategies for promoting a compliant culture within your organization.

Benchmark with Your Peers and Explore
the Top Risk Hot Spots for 2018:

  • Hear a legal update on recently released guidance from
    FDA and DOJ
  • Transform the internal role of the compliance officer
    from policeman to partner
  • Develop compliant relationships with patient advocacy
    groups and charitable foundations
  • Address risks associated with patient support services
  • Create a checklist for third party selection and monitoring
  • Examine risk factors in expanding compliance
    programs globally

Be the first to see the 2018 agenda — Request your copy today!

Previous Attendee Acclaim:

This is the only conference that I am aware of that focuses on compliance for specialty products. The unique forum provides a great opportunity to share best practices
and benchmark programs.

Chief Compliance Officer, Haemonetics

The speaking faculty scope and depth provided an outstanding view of specialty compliance risks
and tools to minimization.

Director, Govt Programs & Commercial Compliance, Prometric Biotherapeutics

This is a phenomenal program, with insightful and real-world examples and solutions for managing risk.

Anonymous

Great information for someone starting out
in specialty pharma.

Associate Director, Compliance, PTC Therapeutics

Compliance Congress for Specialty Products

Proactive Strategies for Managing Risk in Patient Support Services, Specialty Pharmacy Contracting and Non-Promotional Activities

CBI’s Compliance Congress for Specialty Products serves as the life sciences industry’s only conference catered to the unique compliance challenges for specialty bio/pharmaceutical companies, pre- and post-commercialization.

While specialty products are immensely valuable to patients, they also bring unprecedented risks for manufacturers. A comprehensive compliance program is essential to correctly assessing risks, including patient assistance programs, non-commercial activities, third-party relationships and pharmacy contracting. At this fourth annual meeting, take the opportunity to identify and address the top risk areas for specialty product manufacturers and compare strategies for promoting a compliant culture within your organization.

Benchmark with Your Peers and Explore
the Top Risk Hot Spots for 2018:

  • Hear a legal update on recently released guidance from
    FDA and DOJ
  • Transform the internal role of the compliance officer
    from policeman to partner
  • Develop compliant relationships with patient advocacy
    groups and charitable foundations
  • Address risks associated with patient support services
  • Create a checklist for third party selection and monitoring
  • Examine risk factors in expanding compliance
    programs globally

Be the first to see the 2018 agenda — Request your copy today!

Previous Attendee Acclaim:

This is the only conference that I am aware of that focuses on compliance for specialty products. The unique forum provides a great opportunity to share best practices
and benchmark programs.

Chief Compliance Officer, Haemonetics

The speaking faculty scope and depth provided an outstanding view of specialty compliance risks
and tools to minimization.

Director, Govt Programs & Commercial Compliance, Prometric Biotherapeutics

This is a phenomenal program, with insightful and real-world examples and solutions for managing risk.

Anonymous

Great information for someone starting out
in specialty pharma.

Associate Director, Compliance, PTC Therapeutics